July 6 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT RECEIVES ADVERSE NOTICE OF REASSESSMENT FROM CRA
* KNIGHT THERAPEUTICS INC - RECEIVED A NOTICE OF REASSESSMENT FROM CANADA REVENUE AGENCY FOR ITS FISCAL YEAR ENDED DECEMBER 31, 2014
* KNIGHT THERAPEUTICS - CRA NOTICE RELATES TO DISPOSITION OF PRIORITY REVIEW VOUCHER GRANTED ON MARCH 19, 2014, UPON U.S. FDA'S APPROVAL OF IMPAVIDO
* KNIGHT THERAPEUTICS INC - CRA NOTICE PROVIDES THAT KNIGHT IS LIABLE TO PAY TO CRA AN AGGREGATE OF $23.3 MILLION IN ADDITIONAL TAXES AND INTEREST
* KNIGHT THERAPEUTICS INC - INTENDS TO CONTEST CRA NOTICE BY FILING A NOTICE OF OBJECTION TO START APPEALS PROCESS
* KNIGHT THERAPEUTICS INC - IN CONNECTION WITH APPEALS PROCESS, HAS MADE A DEPOSIT OF $23.3 MILLION TO CRA, WILL MAKE ESTIMATED DEPOSIT OF $19.0 MILLION TO QRA
* KNIGHT THERAPEUTICS INC - HAS NOT RECORDED ANY TAX PROVISION FOR TOTAL TAX LIABILITY IN ITS FINANCIAL STATEMENTS
* KNIGHT THERAPEUTICS - LIKELY THAT QUEBEC REVENUE AGENCY WILL PROPOSE SIMILAR ADJUSTMENT WHICH WILL RESULT IN ADDITIONAL TAX LIABILITY OF $19.0 MILLION
* KNIGHT THERAPEUTICS - FINAL DETERMINATION OF TAX AUDITS, RELATED DISPUTES COULD BE DIFFERENT FROM HISTORICAL INCOME TAX PROVISIONS, ACCRUALS